Demand for health risk reductions

Journal of Environmental Economics and Management

Volumn 65, Issue 1, 2013, Pages 87-109

  Cameron, Trudy Ann ^a   DeShazo, J R ^b  

^a UNIVERSITY OF OREGON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benefit cost analysis; Choice model; Illness profiles; Morbidity risks; Mortality risks; Representative national survey; Risk reduction; Risk valuation; Value of a microrisk reduction; Value of a statistical life

Indexed keywords

BENEFIT-COST ANALYSIS; CHOICE MODEL; ILLNESS PROFILES; MORTALITY RISK; RISK REDUCTIONS; RISK VALUATION; VALUE OF A STATISTICAL LIVES;

COST ACCOUNTING; SURVEYS;

RISK PERCEPTION;

ESTIMATION METHOD; HEALTH RISK; INCOME; NUMERICAL MODEL; RISK FACTOR; STATISTICAL ANALYSIS; SURVEYING; WILLINGNESS TO PAY;

EID: 84872267368     PISSN: 00950696     EISSN: 10960449     Source Type: Journal    
DOI: 10.1016/j.jeem.2012.05.008     Document Type: Article

References (70)

1. Alberini A., Cropper M., Krupnick A., Simon N.B. Does the value of a statistical life vary with age and health status? Evidence from the US and Canada. Journal of Environmental Economics and Management 2004, 48:769-792.
2. Alberini A., Cropper M., Krupnick A., Simon N.B. Willingness to pay for mortality risk reductions: does latency matter?. Journal of Risk and Uncertainty 2006, 32:231-245.
3. Aldy J.E., Viscusi W.K. Adjusting the value of a statistical life for age and cohort effects. Review of Economics and Statistics 2008, 90:573-581.
4. Aldy J.E., Viscusi W.K. Age differences in the value of statistical life: revealed preference evidence. Review of Environmental Economics and Policy 2007, 1:241-260.
5. J.E. Aldy, W.K. Viscusi, Age Variation in Workers' Value of Statistical Life, 2003.
6. Ashenfelter O. Measuring the value of a statistical life: problems and prospects. Economic Journal 2006, 116:C10-C23.
7. Ashenfelter O., Greenstone M. Using mandated speed limits to measure the value of a statistical life. Journal of Political Economy 2004, 112:S226-S267.
8. Baker R., Chilton S., Jones-Lee M., Metcalf H. Valuing lives equally: defensible premise or unwarranted compromise?. Journal of Risk and Uncertainty 2008, 36:125-138.
9. Blass A.A., Lach S., Manski C.F. Using elicited choice probabilities to estimate random utility models: preferences for electricity reliability. International Economic Review 2010, 51:421-440.
10. Blomquist G.C., Dickie M., O'Conor R.M. Willingness to pay for improving fatality risks and asthma symptoms: values for children and adults of all ages. Resource and Energy Economics 2011, 33:410-425.
11. Bosworth R.C., Cameron T.A., DeShazo J.R. Demand for environmental policies to improve health: evaluating community-level policy scenarios. Journal of Environmental Economics and Management 2009, 57:293-308.
12. Bosworth R.C., Cameron T.A., DeShazo J.R. Age, Health and Rates of Time Preference. Department of Applied Economics 2011, Utah State University, Logan, UT.
13. Bosworth R.C., Cameron T.A., DeShazo J.R. Willingness to Pay for Public Health Policies to Treat Illnesses, Department of Economics 2012, University of Oregon, Eugene, OR.
14. Cameron T.A. Euthanizing the value of a statistical life. Review of Environmental Economics and Policy 2010, 4:161-178.
15. Cameron T.A., DeShazo J.R. Differential attention to attributes in utility-theoretic choice models. Journal of Choice Modelling 2010, 3:73-115.
16. T.A. Cameron, J.R. DeShazo, Handbook to accompany "demand for health risk reductions" and related papers, Available via the journal's repository of online material, which can be accessed via www.aere.org/journals. Updates may be posted at .http://www.uoregon.edu/.
17. Cameron T.A., DeShazo J.R., Johnson E.H. The effect of children on adult demands for health-risk reductions. Journal of Health Economics 2010, 29:364-376.
18. Cameron T.A., DeShazo J.R., Johnson E.H. Scenario adjustment in stated preference research. Journal of Choice Modelling 2010, 4:9-43.
19. T.A. Cameron, J.R. DeShazo, E.H. Johnson, Willingness to Pay for Health Risk Reductions: Differences by Type of Illness, Working Paper, Department of Economics, University of Oregon, Eugene, OR 97403, 2011.
20. Cameron T.A., DeShazo J.R., Stiffler P. Demand for health risk reductions: A cross-national comparison between the U.S. And Canada. Journal of Risk and Uncertainty 2010, 41:245-273.
21. Corso P.S., Hammitt J.K., Graham J.D. Valuing mortality-risk reduction: using visual aids to improve the validity of contingent valuation. Journal of Risk and Uncertainty 2001, 23:165-184.
22. Costa D.L., Kahn M.E. Changes in the value of life, 1940-1980. Journal of Risk and Uncertainty 2004, 29:159-180.
23. Cutler D.M., Richardson E. Measuring the health of the US population. Brookings Papers on Economic Activity 1997, 217.
24. Cutler D.M., Richardson E. The value of health: 1970-1990. American Economic Review 1998, 88:97-100.
25. Dickie M., List J. Economic valuation of health for environmental policy: comparing alternative approaches. Introduction and overview. Environmental & Resource Economics 2006, 34:339-346.
26. Dow W.H., Philipson T.J., Sala-I-Martin X. Longevity complementarities under competing risks. American Economic Review 1999, 89:1358-1371.
27. Ehrlich I. Uncertain lifetime, life protection, and the value of life saving. Journal of Health Economics 2000, 19:341-367.
28. Evans M.F., Smith V.K. Do we really understand the age-VSL relationship?. Resource and Energy Economics 2006, 28:242-261.
29. Evans M.F., Smith V.K. Measuring how risk tradeoffs adjust with income. Journal of Risk and Uncertainty 2010, 40:33-55.
30. Gayer T., Hamilton J.T., Viscusi W.K. The market value of reducing cancer risk: hedonic housing prices with changing information. Southern Economic Journal 2002, 69:266-289.
31. Gold M.R., Russell L.B., Siegel J.E., Weinstein M.C. Effectiveness in Health and Medicine 1996, Oxford University Press, New York.
32. Graham D.A. Cost-benefit analysis under uncertainty. American Economic Review 1981, 71:715-725.
33. Hall R.E., Jones C.I. The value of life and the rise in health spending. Quarterly Journal of Economics 2007, 122:39-72.
34. Hammitt J.K., Haninger K. Valuing fatal risks to children and adults: effects of disease, latency, and risk aversion. Journal of Risk and Uncertainty 2010, 40:57-83.
35. Hammitt J.K., Liu J.T. Effects of disease type and latency on the value of mortality risk. Journal of Risk and Uncertainty 2004, 28:73-95.
36. Howard R.A. On fates comparable to death. Management Science 1984, 30:407-422.
37. Johnson F.R., Banzhaf M.R., Desvousges W.H. Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approach. Health Economics 2000, 9:295-317.
38. Jones-Lee M. Value of changes in probability of death or injury. Journal of Political Economy 1974, 82:835-849.
39. Jones-Lee M.W., Hammerton M., Philips P.R. The value of safety-results of a national sample survey. Economic Journal 1985, 95:49-72.
40. M.W. Jones-Lee, G. Loomes, D. O'Reilly, P.R. Phillips, The Value of Preventing Non-fatal Road Injuries: Findings of a Willingness-to-pay National Sample Survey, Transportation Research Laboratory, Contractor Report No. 330, Crowthorne, Berkshire, UK, 1993.
41. Kaplow L. The value of a statistical life and the coefficient of relative risk aversion. Journal of Risk and Uncertainty 2005, 31:23-34.
42. Kniesner T.J., Viscusi W.K., Woock C., Ziliak J.P. The value of a statistical life: evidence from panel data. Review of Economics and Statistics 2012, 94:74-87.
43. Kniesner T.J., Viscusi W.K., Ziliak J.P. Policy relevant heterogeneity in the value of statistical life: new evidence from panel data quantile regressions. Journal of Risk and Uncertainty 2010, 40:15-31.
44. Kochi I., Hubbell B., Kramer R. An empirical Bayes approach to combining and comparing estimates of the value of a statistical life for environmental policy analysis. Environmental & Resource Economics 2006, 34:385-406.
45. Krupnick A. Mortality-risk valuation and age: stated preference evidence. Review of Environmental Economics and Policy 2007, 1:261-282.
46. Krupnick A., Alberini A., Cropper M., Simon N., O'Brien B., Goeree R., Heintzelman M. Age, health and the willingness to pay for mortality risk reductions: a contingent valuation survey of Ontario residents. Journal of Risk and Uncertainty 2002, 24:161-186.
47. List J.A. Do explicit warnings eliminate the hypothetical bias in elicitation procedures? Evidence from field auctions for sportscards. American Economic Review 2001, 91:1498-1507.
48. Louviere J., Street D., Carson R., Ainslie A., Deshazo J.R., Cameron T.A., Hensher D., Kohn R., Marley T. Dissecting the random component of utility. Marketing Letters 2002, 13:177-193.
49. Manski C.F. Measuring expectations. Econometrica 2004, 72:1329-1376.
50. Moore M.J., Viscusi W.K. The quantity-adjusted value of life. Economic Inquiry 1988, 26:369-388.
51. Mrozek J.R., Taylor L.O. What determines the value of life? A meta-analysis. Journal of Policy Analysis and Management 2002, 21:253-270.
52. Murphy K.M., Topel R.H. The value of health and longevity. Journal of Political Economy 2006, 114:871-904.
53. Newhouse J.P. Medical-care costs-how much welfare loss. Journal of Economic Perspectives 1992, 6:3-21.
54. O'Conor R.M., Blomquist G.C. Measurement of consumer-patient preferences using a hybrid contingent valuation method. Journal of Health Economics 1997, 16:667-683.
55. OECD, Mortality risk Valuation in Environment, Health and Transport Policies, Organisation for Economic Co-operation and Development, 2012.
56. T.J. Philipson, G. Becker, D. Goldman, K.M. Murphy, Terminal Care and The Value of Life Near Its End, NBER Working Paper No. 15649, 2010.
57. Picone G., Sloan F., Taylor D. Effects of risk and time preference and expected longevity on demand for medical tests. Journal of Risk and Uncertainty 2004, 28:39-53.
58. Rosen S. The value of changes in life expectancy. Journal of Risk and Uncertainty 1988, 1:187-203.
59. Salisbury L.C., Feinberg F.M. Alleviating the constant stochastic variance assumption in decision research: theory, measurement, and experimental test. Marketing Science 2010, 29:1-17.
60. Sloan F.A., Viscusi W.K., Chesson H.W., Conover C.J., Whetten-Goldstein K. Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis. Journal of Health Economics 1998, 17:475-497.
61. Smith V.K., Evans M.F., Kim H., Taylor D.H. Do the near-elderly value mortality risks differently?. Review of Economics and Statistics 2004, 86:423-429.
62. Strand J. Valuation of environmental improvements in continuous time with mortality and morbidity effects. Resource and Energy Economics 2006, 28:229-241.
63. Tolley G., Kenkel D., Fabian R. Valuing Health for Policy: An Economic Approach 1994, University of Chicago Press, Chicago.
64. Tsuge T., Kishimoto A., Takeuchi K. A choice experiment approach to the valuation of mortality. Journal of Risk and Uncertainty 2005, 31:73-95.
65. G. Van Houtven, M. Rousu, J.-C. Yang, C. Pringle, W. Wagstaff, J. DePlatchett, Valuation of Morbidity Losses: Meta-analysis of Willingness-to-pay and Health Status Measures, RTI, for the Food and Drug Administration, Center for Food Safety and Applied Nutrition, Research Triangle Park, NC, 2003.
66. Van Houtven G., Sullivan M.B., Dockins C. Cancer premiums and latency effects: a risk tradeoff approach for valuing reductions in fatal cancer risks. Journal of Risk and Uncertainty 2008, 36:179-199.
67. Viscusi W.K. The value of risk to life and health. Journal of Economic Literature 1993, 31:1912-1946.
68. Viscusi W.K., Aldy J.E. Labor market estimates of the senior discount for the value of statistical life. Journal of Environmental Economics and Management 2007, 53:377-392.
69. Viscusi W.K., Aldy J.E. The value of a statistical life: a critical review of market estimates throughout the world. Journal of Risk and Uncertainty 2003, 27:5-76.
70. Viscusi W.K., Magat W.A., Huber J. Pricing environmental-health risks-survey assessments of risk-risk and risk-dollar trade-offs for chronic bronchitis. Journal of Environmental Economics and Management 1991, 21:32-51.